New scan could spot cancer treatment success in weeks, not months

NCT ID NCT04831138

Summary

This study tested a special type of MRI scan that doesn't require an injection of dye. The goal was to see if this scan could detect changes in blood flow to kidney cancer tumors very early in treatment, potentially showing if the therapy is working weeks before a standard scan could. It involved a small group of people with advanced kidney cancer who were getting anti-angiogenic therapy or immunotherapy.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RENAL CELL CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • UT Southwestern Medical Center

    Dallas, Texas, 75390, United States

Conditions

Explore the condition pages connected to this study.